Clinical Trial Update: Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating the lopinavir/ritonavir combination at three different doses in individuals with Acquired immunodeficiency syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Kirby Institute | Conditions: Acquired Immunodeficiency Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2011-03-29